| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 04/02/2009 | WO2009042081A1 Valomaciclovir polymorphs |
| 04/02/2009 | CA2700227A1 Valomaciclovir polymorphs |
| 04/01/2009 | EP2041136A2 Selective antagonists of a2a adenosine receptors |
| 04/01/2009 | EP2041135A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 03/31/2009 | US7511139 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 03/31/2009 | US7510736 Using temperature variation to isolate epigallocatechin (EGC) and epigallocatechin gallate (EGCG) from green and/or white tea |
| 03/26/2009 | WO2009037473A2 Nucleobase characterisation |
| 03/26/2009 | WO2009037357A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | US20090082566 Di- and tri-peptide mono- and di-esters of acyclovir and gancyclovir and derivatives; esters have sufficient hydrophilicity to be formulated into pharmacologically active compositions such as aqueous solutions, eye drops; treating herpes simplex types 1, 2, varicella zoster virus, human cytomegalovirus |
| 03/26/2009 | US20090082332 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 03/26/2009 | CA2700082A1 Nucleobase characterisation |
| 03/26/2009 | CA2699817A1 Benzimidazole nf- kappab inhibitors |
| 03/25/2009 | EP2038041A2 Therapeutic compounds and their use in cancer |
| 03/25/2009 | EP1377579B1 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 03/25/2009 | CN100471857C Purine derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009034386A1 Derivatives of adenine and 8-aza-adenine and uses thereof-796 |
| 03/19/2009 | US20090076270 Drying process for preparing crystalline solid famciclovir |
| 03/19/2009 | US20090076041 Acyclic nucleoside derivatives |
| 03/19/2009 | US20090076040 Deuterium-enriched valganciclovir |
| 03/19/2009 | US20090076039 Deuterium-enriched valacyclovir |
| 03/19/2009 | US20090076038 Deuterium-enriched entecavir |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/17/2009 | CA2355712C Antiviral nucleoside analogues |
| 03/12/2009 | WO2009031576A1 Process for producing valacyclovir hydrochloride crystal |
| 03/12/2009 | WO2009018106A3 Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 03/12/2009 | WO2008094737A3 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 03/12/2009 | US20090069347 2-phenoxy pyrimidinone analogues |
| 03/12/2009 | US20090069289 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2032797A2 Adenosine a2b receptor antagonists |
| 03/11/2009 | CN100467470C Improved preparation process of 8-chlorotheophylline |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CA2601204A1 A process for the manufacture of famciclovir using phase-transfer catalysts |
| 03/10/2009 | US7501429 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
| 03/10/2009 | US7501426 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| 03/05/2009 | WO2009028280A1 Pyrazolecarboxylic acid derivative, method for producing the same and bactericide |
| 03/05/2009 | WO2009027746A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/05/2009 | WO2009027732A1 5-6-bicyclic heteroaromatic compounds with antibacterial activity |
| 03/05/2009 | WO2009027475A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases |
| 03/05/2009 | WO2008131502A3 Antiviral compounds of the adamantane type |
| 03/05/2009 | US20090062538 Amorphous valganciclovir hydrochloride |
| 03/05/2009 | US20090062314 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
| 03/05/2009 | CA2696767A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/04/2009 | EP2029598A1 2-thioxanthine derivatives acting as mpo-inhibitors |
| 03/04/2009 | EP2029597A2 Purine analogs |
| 03/04/2009 | EP2029143A2 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 03/04/2009 | EP1706405B1 4'-substituted carbovir- and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity |
| 03/04/2009 | EP1601649A4 A1 adenosine receptor antagonists |
| 03/04/2009 | EP1379269B1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
| 03/04/2009 | CN101379061A Inhibitors of E1 activating enzyme |
| 03/04/2009 | CN100465174C A method for preparing optics pure abacavir |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054312 SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
| 02/25/2009 | EP2028182A1 Cysteine protease inhibitors |
| 02/25/2009 | EP2027086A2 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 02/25/2009 | CN101372487A Preparation of valaciclovir hydrochloride and pharmaceutically acceptable salt thereof |
| 02/24/2009 | US7495095 useful in obtaining an oligonucleic acid capable of recognizing a specific base and transferring a nitrosyl group in a sequence-specific manner; sequence specific mutagenesis |
| 02/24/2009 | US7495006 reverse transcriptase (polymerase) inhibitor; viricide, antiproliferative agent; Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, AIDS |
| 02/24/2009 | US7495005 Antidiabetic agents; antiarthritic agents; obesity; graft verses host disease; osteoporosis |
| 02/24/2009 | US7495004 Purine derivatives as liver X receptor agonists |
| 02/24/2009 | US7495003 e.g. 1-(naphthyl-1-ylmethyl)-3-(methoxycarbonylmethyl)-7-(but-2-ynyl)-8-(3-amino-piperidin-1-yl)-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
| 02/24/2009 | US7495002 e.g. 1-[(3-methyl-isoquinolin- 1 -yl)methyl]-3-methyl-7-(2-butyn- 1 -yl)-8-[(2-amino-ethyl) -methylamino]-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
| 02/19/2009 | WO2009022008A1 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative |
| 02/19/2009 | US20090048275 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 02/19/2009 | US20090048203 Substituted adenines and the uses thereof |
| 02/19/2009 | US20090047249 Modulators of toll-like receptor 7 |
| 02/18/2009 | EP2024380A2 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 02/18/2009 | EP2024360A2 Substituted pyrazolopyrimidines |
| 02/18/2009 | EP2024333A2 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 02/18/2009 | EP2023932A1 Methods for preventing or treating acute and chronic pain |
| 02/18/2009 | CN101367856A Methods and compositions for treating hepatitis c virus |
| 02/18/2009 | CN101367803A Method for extracting theine from green tea |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/12/2009 | WO2009018656A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2008116129A3 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 02/12/2009 | WO2008008539A3 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | US20090042768 Purine derivatives and their use for treatment of autoimmune diseases |
| 02/12/2009 | CA2696247A1 Preparation of synthetic nucleosides via .pi.-allyl transition metal complex formation |
| 02/12/2009 | CA2693495A1 Viral polymerase inhibitors |
| 02/05/2009 | WO2008116912A3 Purinyl derivatives and their use as potassium channel modulators |
| 02/05/2009 | US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
| 02/04/2009 | EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 01/29/2009 | WO2009012573A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/29/2009 | US20090030019 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090029349 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | CA2693290A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/28/2009 | EP2018382A2 Purine derivatives as adenosine receptor activator |
| 01/28/2009 | EP2018381A2 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists |
| 01/28/2009 | CN100455583C 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9- 4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same |
| 01/27/2009 | US7482337 Antidiabetic agents; dietetics; antiarthritic agents; osteoporosis; angiotensin converting enzyme inhibitor |
| 01/22/2009 | US20090023723 Purinone derivatives for treating neurodegenerative diseases |